title: Urticarial vasculitis due do infliximab.
authors.forename: J
authors.initials: J
authors.lastname: Goulão
authors.forename: H
authors.initials: H
authors.lastname: Cunha
authors.forename: I
authors.initials: I
authors.lastname: Anes
authors.forename: E
authors.initials: E
authors.lastname: Bártolo
authors.forename: C
authors.initials: C
authors.lastname: Furtado
authors.forename: P
authors.initials: P
authors.lastname: Serrano
authors.forename: F M
authors.initials: FM
authors.lastname: Brandão
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D014581:Urticaria / Q000139:chemically induced* / Q000473:pathology; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab